Please ensure Javascript is enabled for purposes of website accessibility

Illinois Postponing Current Round of Recreational-Dispensary Licensing

By Eric Volkman – Apr 30, 2020 at 7:29PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's unclear how long the delay will last.

The new batch of recreational-marijuana dispensary licenses in Illinois that was supposed to be awarded by Friday, May 1 will not be approved after all. The state has postponed the allocation of as many as 75 new permits, due to delays related to the SARS-CoV-2 coronavirus outbreak.

The postponement follows a modified "stay-at-home" order for the state's residents that comes into force on Friday.

The delay will be enshrined in an executive order signed by Governor J.B. Pritzker, according to a statement released by the Illinois Department of Financial and Professional Regulation (IDFPR).

Generic marijuana dispensary sign.

Image source: Getty Images.

"The requirement will be suspended for the duration of the ongoing Gubernatorial Disaster Proclamations, or until IDFPR otherwise announces a new date. IDFPR will provide a public notice announcing the new date when licenses will be issued and will seek to do so as soon as feasible," IDFPR wrote in the statement. It did not speculate as to where the reset date might land.

Under the Proclamations, many businesses have been temporarily closed, although dispensaries have been classified as "essential businesses."

News of the licensing postponement will come as a heavy disappointment to potential recreational-dispensary operators. More than 700 applications have been filed for the new licenses.

The delay will likely benefit existing dispensary operators, at least to some degree, given the current constraints on their businesses. Two Illinois-headquartered cannabis companies that have built up relatively wide dispensary networks in their home state are Green Thumb Industries (GTBIF 1.08%) and Cresco Labs (CRLBF 5.45%). Neither Green Thumb nor Cresco has publicly commented on the licensing postponement.

On Thursday, both stocks slumped more or less in line with the declines recorded by the wider equities market. Green Thumb fell nearly 1% on the day, while Cresco dipped by 1.1%.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Cresco Labs Inc. and Green Thumb Industries. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Green Thumb Industries Stock Quote
Green Thumb Industries
GTBIF
$9.37 (1.08%) $0.10
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$2.71 (5.45%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
326%
 
S&P 500 Returns
102%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.